MAVA Member NEA leads $36.4M Series B for Aetion

Aetion, a New York-based biopharma customer analytics firm, raised $36.4 million in Series B funding. New Enterprise Associates led the round and was joined by investors including Amgen Ventures, Flare Capital Partners, Lakestar, and Oxeon Ventures.

Click here to learn more.

2018-05-23T09:08:27+00:00May 22nd, 2018|